Company Overview and News

 
PepsiCo, HUL, among others pulled up for misleading ads

2018-10-18 freepressjournal.in
Mumbai : Advertising sector watchdog ASCI investigated complaints against 208 advertisements in June, of which 179 were regarding misleading claims including those of Reliance Jio, SpiceJet, PepsiCo India, Hindustan Unilever, among others. It noted that out of the 208 advertisements, the advertisers promptly ensured corrective action in 63 of them as soon as the complaints were received. The consumer complaints council (CCC) of Advertising Standards Council of India (ASCI) upheld 89 advertise-ments from a total of 145 evaluated by them.
500696 HINDUNILVR

 
Reliance Jio, SpiceJet, PepsiCo India, Hindustan Unilever and others pulled up for misleading ads

2018-10-17 financialexpress
Advertising sector watchdog ASCI investigated complaints against 208 advertisements in June, of which 179 were regarding misleading claims including those of Reliance Jio, SpiceJet, PepsiCo India, Hindustan Unilever, among others. It noted that out of the 208 advertisements, the advertisers promptly ensured corrective action in 63 of them as soon as the complaints were received. The consumer complaints council (CCC) of Advertising Standards Council of India (ASCI) upheld 89 advertisements from a total of 145 evaluated by them.
500696 HINDUNILVR

 
[email protected]: Market to consolidate in near term, but more pain ahead; high PE stocks most vulnerable

2018-10-15 moneycontrol
Shares may consolidate in the medium term, but there is more pain ahead for the market, says CNBC-TV18 Consulting Editor Udayan Mukherjee in an interview with Moneycontrol Editor Santosh Nair.
500696 HINDUNILVR

 
Market to consolidate in the near term, but more pain ahead; high PE stocks most vulnerable: Udayan

2018-10-15 moneycontrol
Shares may consolidate in the medium term, but there is more pain ahead for the market, says CNBC-TV18 Consulting Editor Udayan Mukherjee in an interview with Moneycontrol Editor Santosh Nair.
500696 HINDUNILVR

4
#MeToo: Nifty companies record 588 sexual harassment complaints in FY18

2018-10-15 moneycontrol
The #MeToo wave against sexual harassment is in full swing. Corporate India has also been impacted by it, with companies like Tata Motors conducting an investigation into an alleged incident. However, these are not isolated instances. A deep dive by Moneycontrol showed that 588 cases of sexual harassment were filed across Nifty companies in FY18.
ICICIBANK 532174 IBN 500696 HINDUNILVR 500570 TATAMOTORS TTM

4
#MeToo: Nifty companies reported 588 cases of sexual harassment in FY18

2018-10-15 moneycontrol
The #MeToo wave against sexual harassment is in full swing. Corporate India has also been impacted by it, with companies like Tata Motors conducting an investigation into an alleged incident. However, these are not isolated instances. A deep dive by Moneycontrol showed that 588 cases of sexual harassment were filed across Nifty companies in FY18.
ICICIBANK 532174 IBN 500696 HINDUNILVR 500570 TATAMOTORS TTM

1
Sensex slips 71 points on negative economic data, weak rupee

2018-10-15 freepressjournal.in - 1
Mumbai: The BSE benchmark Sensex after reclaiming the 35,000-mark fell 71 points to quote at 34,662.73 Monday, as the IIP slipped to a three-month low in August and retail inflation rose marginally in September. Besides, weak Asian cues on worries over China-Us trade dispute influenced sentiment.
BAJAJ-AUTO ALNSE AXB IBN HINDUNILVR 532977 BHRQY 533278 VEDL 532215 AXBKY 532454 AXBA ICICIBANK 500470 TTST TATASTEEL TATLY AXISBANK 532174 500696 BHARTIARTL CLNDY COALINDIA

 
HUL share price plunges 4% after despite strong Q2 results; what brokerages say

2018-10-15 financialexpress
HUL share price: Shares of FMCG major Hindustan Unilever Ltd plunged as much as 4.5% on Monday, despite reporting results in line with estimates in the latest quarter. HUL has reported a 19.5% rise in net profit to Rs 1,525 crore, even as revenue came in higher by 11.45% on year to Rs 9,138 crore. Notably, this is the fourth consecutive quarter of double digit volume growth.
500696 HINDUNILVR

 
Sensex slips 71 points on negative economic data, weak rupee

2018-10-15 thehindubusinessline
The BSE benchmark Sensex after reclaiming the 35,000-mark fell 71 points to quote at 34,662.73 Monday, as the IIP slipped to a three-month low in August and retail inflation rose marginally in September.
BAJAJ-AUTO ALNSE AXB IBN HINDUNILVR 532977 BHRQY 533278 VEDL 532215 AXBKY 532454 AXBA ICICIBANK 500470 TTST TATASTEEL TATLY AXISBANK 532174 500696 BHARTIARTL CLNDY COALINDIA

 
HUL shares plunge 3%

2018-10-15 thehindubusinessline
Hindustan Unilever Ltd's shares plunged as much as 3 per cent to Rs 1,522.35 as CLSA has raised margin concerns.
500696 HINDUNILVR

 
HUL Q2: Rising input costs face off against healthy demand growth

2018-10-15 livemint
Indian consumers have been vocal critics of rising fuel prices. The government had to finally relent and lower excise duties, and even asked state-run petroleum firms to cut prices. Viewed in this backdrop, Hindustan Unilever Ltd’s (HUL’s) cautious approach to price hikes makes sense. A sharp increase in consumer product prices in the run-up to elections next year may attract unwanted attention.
500696 TRI HINDUNILVR

1
Three of top-10 firms lose Rs 1 lakh cr in m-cap; TCS hit hard

2018-10-14 thehindubusinessline
Three of the 10 most valued Indian companies together witnessed an erosion of Rs 1,07,026.12 crore in market capitalisation last week, with IT major Tata Consultancy Services (TCS) taking the biggest knock.
500325 KMBKY RELIANCE HINDUNILVR TTNQY MRZUY 532500 532540 HDB MARUTI 500180 RIGD KOTAKBANK 500696 HDFCBANK TCS 500247 RLNIY SBAZ

1
Three of top-10 cos lose Rs 1 lakh crore in m-cap; TCS takes biggest knock of Rs 85,330.17 crore

2018-10-14 financialexpress
Three of the 10 most valued Indian companies together witnessed an erosion of Rs 1,07,026.12 crore in market capitalisation last week, with IT major TCS taking the biggest knock. Tata Consultancy Services (TCS), ITC and Infosys suffered a decline in their valuation for the week ended Friday, whereas RIL, HDFC Bank, Hindustan Unilever Ltd (HUL), HDFC, SBI, Kotak Mahindra Bank and Maruti Suzuki India finished with gains.
500325 KMBKY RELIANCE HINDUNILVR TTNQY MRZUY 532500 532540 HDB MARUTI 500180 RIGD KOTAKBANK 500696 HDFCBANK TCS 500247 RLNIY SBAZ

 
Hindustan Unilever Q2 profit rises 19.51% on firm sales

2018-10-13 freepressjournal.in
New Delhi: FMCG major Hindustan Unilever (HUL) on Friday reported a 19.51 per cent increase in net profit to Rs 1,525 crore for the September 2018 quarter on account of double digit growth across categories. The company had posted a net profit of Rs 1,276 crore during the same period last fiscal. Sales during the quarter stood at Rs 9,138 crore as against Rs 8,199 crore in the year-ago period, up 11.
500696 HINDUNILVR

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...